FRAX Spain may overestimate the need for anti-osteoporotic treatment compared to bone densitometry (DEXA) in patients with prostate cancer undergoing Androgen Deprivation Therapy (ADT) and new Antiandrogens Signalling-Inhibitors generation (ASI) | Publicación